A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A practical, risk-based strategy...